| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |